Tatva Chintan Pharma Chem Limited (TATVA.NS) NSE
1,260.10
-8.6(-0.68%)
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
1,260.10
-8.6(-0.68%)
Currency In INR
| Market Cap | 16.56B |
| Enterprise Value | 16.81B |
| P/E Ratio | 89.87 |
| PEG Ratio | 0.7 |
| Price/Sales Ratio | 6.15 |
| Price/Book Ratio | 3.9 |
| Enterprise/Revenue | 6.29 |
| Enterprise/EBITDA | 38.93 |
| Fiscal Year | March 31, 2025 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | 0.07 |
| Operating Margin | 0.15 |
| Return On Assets | 0.04 |
| Return On Equity | 0.04 |
| Revenue | 3.83B |
| Revenue/Share | 205.24 |
| Gross Profit | 1.84B |
| EBITDA | 342.13M |
| Net Income | 57.13M |
| Diluted EPS | 2.44 |
| Total Cash | 178.47M |
| Total Cash/Share | 7.64 |
| Total Debt | 830.13M |
| Total Debt/Equity | 0.11 |
| Current Ratio | 1.95 |
| Book Value Per Share | 322.85 |
| 52-Week Change | 64.88 |
| 52-Week High | 1,610 |
| 52-Week Low | 749.65 |
| Moving Average 50 Days | 1,209.55 |
| Moving Average 200 Days | 1,236.14 |
| Average Volume | 51,512 |
| Shares Outstanding | 23.39M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 1 |
| Trailing Annual Dividend Yield | 0.08 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |